MIC current news
The updated ‘National Malaria Treatment Guidelines 2017’ (final draft version) can be accessed on the NICD website (www.nicd.ac.za).
Ning and colleagues recently published their research in the Journal of Psychopharmacology. Their study looked at reducing the dose of olanzapine or risperidone in stable schizophrenic patients and the effect on cognitive function and symptoms.
We need your help, please. We are conducting a research study to understand healthcare worker knowledge of parts of the new ART guidelines. The survey data will be collected anonymously.
There is an optional prize draw after completion (details stored separately from survey answers, to protect anonymity). To participate, click here.
A systematic review and meta-analysis on the use of honey for URTI symptom management was recently published in BMJ Evidence-based Medicine.
New data from the Tsepamo study in Botswana has shown that the prevalence of neural tube defects in women on dolutegravir-based regimens appears to have stabilised at 0.2%.
The NDoH is now recommending dexamethasone (or equivalent) for patients with severe COVID-19 disease requiring respiratory support in the form of ventilation or supplemental oxygen.
We are excited to tell you that we have great new posters (based on the national and Western Cape 2019 guidelines) available for download – free – from our website.
A medicine safety letter highlights the risk of acute kidney injury in patients treated with fluoroquinolones concomitantly with ace-inhibitors (ACEIs) or angiotensin receptor blockers (ARBs).
We've made a list of useful and reliable links to information on COVID-19.
An article in the February Lancet discussed lessons learnt from eleven countries that are moving toward universal health coverage (UHC). An interesting read, as South Africa negotiates a National Health Insurance system.
Prescription drugs were previously assigned pregnancy categories A, B, C, D and X, which essentially over-simplified the issue. These categories will now be replaced with three detailed sub-sections that describe risks in a real world context.